Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 590

1.

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

Moul JW, Sesterhenn IA, Connelly RR, Douglas T, Srivastava S, Mostofi FK, McLeod DG.

JAMA. 1995 Oct 25;274(16):1277-81.

PMID:
7563532
2.

Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients.

Moul JW, Connelly RR, Mooneyhan RM, Zhang W, Sesterhenn IA, Mostofi FK, McLeod DG.

J Urol. 1999 Aug;162(2):394-7.

PMID:
10411045
3.

African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.

Sanchez-Ortiz RF, Troncoso P, Babaian RJ, Lloreta J, Johnston DA, Pettaway CA.

Cancer. 2006 Jul 1;107(1):75-82.

4.

Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.

Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ.

Urology. 2000 Jul;56(1):87-91.

PMID:
10869631
5.

Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.

Eastham JA, Carver B, Katz J, Kattan MW.

Prostate. 2002 Mar 1;50(4):236-40.

PMID:
11870801
6.

Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.

Klaassen Z, Howard L, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ.

Cancer Epidemiol. 2015 Dec;39(6):1066-70. doi: 10.1016/j.canep.2015.09.007. Epub 2015 Oct 6.

8.

Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens.

Pettaway CA, Troncoso P, Ramirez EI, Johnston DA, Steelhammer L, Babaian RJ.

J Urol. 1998 Aug;160(2):437-42.

PMID:
9679893
9.

Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Freedland SJ, Amling CL, Dorey F, Kane CJ, Presti JC Jr, Terris MK, Aronson WJ; Shared Equal Access Regional Cancer Hospital Database Study Group.

Urology. 2002 Oct;60(4):670-4.

PMID:
12385931
10.
11.

Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.

Cross CK, Shultz D, Malkowicz SB, Huang WC, Whittington R, Tomaszewski JE, Renshaw AA, Richie JP, D'Amico AV.

J Clin Oncol. 2002 Jun 15;20(12):2863-8.

PMID:
12065563
12.
13.

Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.

Henderson RJ, Eastham JA, Culkin DJ, Kattan MW, Whatley T, Mata J, Venable D, Sartor O.

J Natl Cancer Inst. 1997 Jan 15;89(2):134-8.

PMID:
8998182
15.

Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.

Bianco FJ Jr, Wood DP Jr, Grignon DJ, Sakr WA, Pontes JE, Powell IJ.

J Urol. 2002 Aug;168(2):479-82.

PMID:
12131292
16.

Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.

Vijayakumar S, Winter K, Sause W, Gallagher MJ, Michalski J, Roach M, Porter A, Bondy M.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):17-25.

PMID:
9422553
17.

Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.

Bissonette EA, Fulmer BR, Petroni GR, Moul JW, Theodorescu D.

J Urol. 2001 Oct;166(4):1328-31; discussion 1331-2.

PMID:
11547067
18.

Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.

Hamilton RJ, Aronson WJ, Presti JC Jr, Terris MK, Kane CJ, Amling CL, Freedland SJ.

Cancer. 2007 Nov 15;110(10):2202-9.

19.

Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.

Moses KA, Chen LY, Sjoberg DD, Bernstein M, Touijer KA.

BMC Urol. 2014 Dec 11;14:98. doi: 10.1186/1471-2490-14-98.

20.

Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.

Smith DS, Carvalhal GF, Mager DE, Bullock AD, Catalona WJ.

J Urol. 1998 Nov;160(5):1734-8.

PMID:
9783942

Supplemental Content

Support Center